Using continuous glucose monitoring to improve diabetes management during pregnancy
Continuous glucose monitoring for management of type 2 diabetes in pregnancy (CGM2 trial)
This study is looking at how using continuous glucose monitors can help pregnant people with type 2 diabetes keep their blood sugar in check better than traditional methods, with the goal of improving health for both moms and their babies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10776545 on NIH RePORTER |
What this research studies
This research investigates how continuous glucose monitoring (CGM) can help pregnant individuals with type 2 diabetes manage their blood sugar levels more effectively than traditional self-monitoring methods. The study aims to determine the impact of CGM on maternal and neonatal health outcomes, particularly in reducing complications associated with diabetes during pregnancy. By addressing the challenges of glycemic control and considering social factors that affect health, the research seeks to provide a clearer understanding of optimal glucose levels for pregnant individuals with type 2 diabetes. Participants will be monitored continuously to gather data on their glucose levels and health outcomes throughout their pregnancy.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant individuals diagnosed with type 2 diabetes mellitus.
Not a fit: Patients who are not pregnant or those with type 1 diabetes may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for both mothers and their newborns by providing better management of blood sugar levels during pregnancy.
How similar studies have performed: Previous research has shown that continuous glucose monitoring can significantly improve outcomes in pregnancies affected by type 1 diabetes, suggesting potential benefits for type 2 diabetes as well.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Battarbee, Ashley Nicole — University of Alabama at Birmingham
- Study coordinator: Battarbee, Ashley Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.